Study Finds Chemotherapy Antidote Could Improve Recovery After Chemotherapy-Induced Kidney ... is a major cause of kidney transplant failure. There are no effective drugs to treat BKPyV.

AstraZeneca has licensed in an antisense drug from Ionis Pharmaceuticals to treat kidney disease in a deal worth up to $330 million. Antisense drugs contain non-coding strands of mRNA that block ...

The pharma will pay $800 million for the biotech, which was launched nearly two decades ago by Alnylam and Ionis to advance ...

My husband got a call in the middle of the night while I was in an induced coma to prepare ... I was given a lifesaving drug to treat a possible rare disease — one of the 5% of rare diseases ...

Orphan drug specialist Amicus Therapeutics is paying Dimerix $30 million cash for U.S. rights to the phase 3 prospect DMX-200 ...

Novartis has committed another $1.7 billion to its ambition to become a kidney disease leader. The Swiss drugmaker is making ...